Robert Azelby - Jan 27, 2022 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
President & CEO, Director
Signature
/s/ Alan Hambelton, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 04:13 PM
Previous filing
Aug 9, 2021
Next filing
Nov 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Stock Option (Right to Buy) Award $0 +500K $0.00 500K Jan 27, 2022 Common Stock 500K $8.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/48th of the shares will vest on each monthly anniversary of January 27, 2022.